Standardizing blood components would allow better monitoring of the effectiveness of transfusion
Are transfusion guidelines evidence-based?
Clinical trials and systematic reviews
Biology of stem cell mobilization
Developmental plasticity of the bone marrow derived cells
Risk management in transfusion medicine
The use of haemovigilance data to increase safety in transfusion medicine
The role of diagnostic testing to identify congenital vs acquired disorders of hemostasis and to optimize the management of Perioperative bleeding
Disseminated intravascular coagulation
Molecular methods in blood grouping
The HLA system
Platelets
FFP
Is the landscape for blood collection and distribution changing in Europe?
Adopting the EU directive
The EU directive implemented into the legal act for polish blood transfusion service
Multicomponent donation
Preoperative plasma exchange therapy in patients undergoing high risk cardiac surgery
Photopheresis as monotherapy in the treatment of chronic GVDH
Collection in pediatric patients
Alternative methods for prevention of infection transmission (pathogen inactivation etc.), cost-benefit considerations
Quality and stability of methylene blue-treated plasma prepared under worst case conditions
Photodynamic inactivation of human hepatitis B virus in plasma as revealed by long-range PCR
Safety of fresh frozen plasma inactivated with the Theraflex methylene blue system (FFP-MB)
Cytokine levels in pathogen-inactivated and gamma-irradiated platelet concentrates
Transfusion-related acute lung injury
Transfusion-associated graft versus host disease
Four-year cumulative incidence of serious adverse transfusion events in the Quebec hemovigilance system
Reevaluation of TRALI cases based on the recommended criteria
Can haemolytic transfusion reactions be avoided by better laboratory practice?
Transfusion-related acute lung injury (TRALI)
New anticoagulants in the treatment of thromboembolism
Home-made and commercial fibrin glue in liver surgery
Recombinant factor VIIa
Transplanted stem cell apheresis products containing tumor cells and patient survival
Large volume vs. standard mononucrear cell (MNC) harvesting for peripheral blood stem cell transplantation
Enrichment of natural killer cells from peripheral blood and whole blood derived buffy coats for anti-tumour therapy
Inducible knockdown of hla expression
What is the impact of audits on transfusion practices?
Informed consent in transfusion medicine
Reporting of transfusion errors
8 years of SHOT data 1996-2004
Passing the borders
Emerging pathogens
New methods and current trends in donor testing (for infection)
Evaluation of in vivo red blood cell recovery after processing with a new filter designed to reduce prions
Comparative efficacy of bacterial culture versus pathogen inactivation to reduce the risk of transfusion-associated sepsis
Should HBV NAT be implemented in French blood donors?
Combined detection of hepatitis C virus core antigen and antibody as an alternative to nucleic acid testing in blood screening
Partial D and its clinical significance
Fluorescence cytometry for completely automated immunohematology testing
Noninvasive prenatal genotyping on cell free fetal DNA in maternal plasma
Determination of the affinity of anti-D present in the serum of immunized subjects and in anti-D Ig preparations by a method using unlabeled antibodies
Lyophilized platelets (Lyo P) used for the detection of HPA antibodies by MAIPA assay
RHD (201R 223V) allele cluster analysis in different ethnic populations refines RHD phylogeny in humans by identification of RHD (223V) and new aberrant D alleles
Developing transfusion strategy in surgery
Transfusion strategies in pediatrics
Transfusion triggers and the influence of cell storage
Effects of red blood cell storage on therapeutic effectiveness in neonatal transfusion
Fully tested fresh unrefrigerated whole blood usage for major surgery
Transfusion practice for coronary artery bypass surgery in Greece
Platelet transfusions in newborns affected with thrombocytopenia
Financing tools for the blood transfusion service of Serbia
Apheresis studies in Turkey and working plants
Organisation of the blood transfusion service in Bulgaria
Establishing a nationally coordinated blood transfusion service in Serbia
60 years of the national blood transfusion institute in Serbia
The problems of blood service in Russia
Calculating the cost of blood in Turkey
Clinical and serological profile of blood donors with a positive direct antiglobulin test (DAT)
Health history questionnaire-views and opinions of blood donors
Analysis of blood donor's deferral in national institute for transfusion medicine - Skopje for the last five years (2000-2004)
Regruting blood donors in multiethnical environment
Prevalence of HCV-infections among blood donors in north-eastern Poland in years 1998-2004
Prevalence of the antibody to the HBV core protein (anti-Hbc) in blood donors
The quest for a zero risk blood supply may decrease overall transfusion safety
The knowledge level of university youth about blood donation and how to encourage them to donate
Low prevalence of IgA deficiency in Indian population
Blood donation in the borders of the Hellenic territory
The evaluation of immunohematological and serological data in blood donors of Turkish Red Crescent Blood Center, Izmir, Turkey
Comparison evaluation of laboratory findings in iron deficiency and some related factors in frequent and first time female blood donors in blood transfusion center of Tehran in 2004
Adverse donor reactions in mobile donation sessions organized by associations of volunteers
Deferral of volunteer blood donors at blood donation sessions organized by community-based associations
Genotype 1B of hepatitis C virus is the most frequent in blood donors
Kell blood group system and rare blood donors
Reactions in blood donors
Some attitudes about first time blood donation - high school students survey
Risk behavior among blood donors who give blood in order to be tested for HIV in Shiraz blood transfusion in 2003
Awareness of patient's companions regarding blood donation who visited Shiraz Medical University Hospitals (Faghihi and Namazi) on the first half of 2003
True HIV seroprevalence in Shiraz blood donors in 2003
A survey of positive and negative blood donation's motivation who referred to Shiraz blood transfusion service in the first of half of 2003
Surveying the frequency of people who have donated blood for the HIV check up at Shiraz blood transfusion organization
A case - controlled study of contributing factor for vasovegal reaction in blood donors
A study on blood donors with bruises and hematomas following blood donations
Comparison of iron loss in whole blood donors
Impact of the campaign educational system on adolescents
Women and blood donation in Cyprus - a detailed study
Rewarding phlebotomists for enrolling volunteer blood donors
Hemoglobin color scale and donor approval
A motivational comparison between people recruited by health professionals to give blood and non-remunerated voluntary blood donors
Motives for voluntary blood donoring among high school children - our anticipation
Adverse reactions in 2 blood donors taking beta-blocking antihypertensive medications
Effects of confusing publicity about transformation of blood transfusion service in society under transition
Serious adverse reactions and injuries or accidents to donors during and after blood donation
Donated-blood losses due to blood donor deferrals in Polish Regional Blood Centers
Blood donation, a way of life
Blood donation against prejudice
Clinical evaluation of a non-invasive technique for hemoglobin determination in blood donors
The effect of short-term, temporary deferral on blood donor return rates and subsequent blood donations
Woman - blood donor
Comparison of serum beta 2-microglobulin (β-MG) between HBsAg positive donor and healthy control
Trends of transfusion transmissible infections in directed blood donors vs. voluntary and replacement donors
Safe blood for transfusion - by providing qualitative donors
Questionnaire on 2700 subjects-students, their knowledge and motivation on blood donation
The donor data and the details of blood application of the North West Transdanubian region of Hungary
Implementation of 2RBC collection using Haemonetics MCS®+
Risk from first-time blood donors
The effectiveness of Fenvall Amicus and CS 3000+ for platelet apheresis on double dose
Comparison of Cobe spectra and Cobe Trima - analysis
Treatment of cell-affected haematological disorders and abnormalities
Platelet function abnormalities among platelet donors
Autologous peripheral blood stem cell collection in small children and adolescents
Maternal platelet apheresis for treatment of neonatal alloimmune thrombocytopenia
Hemostasis indices correction in obstetrical complications
Extracorporeal photochemotherapy
Therapeutic plasma exchange procedures performed during 2002-2004 - complications
Granulocyte transfusions for successful treatment of critically ill neutropenic patients with septic complications
Adverse events during platelet apheresis with two types of automated cell separators
Quality assessment of FFP collected as a by-product of plateletpheresis
Influence of platelet apheresis procedure on platelet aggregation
The role of intensive plasmatic exchange (IPE) in the treatment of thrombotic thrombocytopenic microangiopathy syndrome (TTMS)
Effects of storage on coagulation factors in plasma obtained by automated plateletpheresis
Case report
Extracorporeal photochemotherapy (ECP)
Quality parameters of two WBC-reduced RBC units collected by apheresis
PA-IA - protein A immunoadsorption - method of efficient extracorporeal removal of pathological autoantibodies
Impact of product volume in erythrocytes depletion of bone marrow harvest using cell separating device
Platelet concentrates obtained by apheresis procedure-correlation between the initial count and the final concentration
Therapeutic apheresis (TA) in Croatian hospitals - adherence to respectable guidelines
Software for the management of the Scansystem bacterial detection method
Monitoring of errors in department for blood testing in Blood Transfusion Institute Novi Sad -opportunity to minimise errors and cost analysis
An ISO standard for blood transfusion?
Residual leukocytes in leukoreduced cellular blood products - evaluation by flow cytometry
Web-based outcome review
A fast and rapid method to determine the ATP content in packed red blood cells
Problems and corrective actions regarding materials used in blood collection and processing
Blood bank certification for ISO 9001:2000
Equipment management in the national blood transfusion service in Serbia
Added value and financial impact of the Vista Information System in three bloodcenters throughout Europe
Establishment of national quality system in blood transfusion service in Serbia
Statistical process control in blood production
Traceability of blood from donor to recipient in Western Uganda
External quality assessment of blood grouping
The importance of ISO 15189-quality system in increasing safety of blood transfusion
Why guidelines on information security in blood banking?
Measurement system analysis of counting blood cells for blood components quality control
Process approach Guide-Lines for Quality Management System proper implementation in transfusion services
The Blood Screening System 400 automated high-throughput NAT system for simultaneous screening of HCV, HBV and HIV nucleic acids
Technical standards for safe storage and transport of blood components and blood samples
Implementation of ISO 9001
Studies of the relation between blood parameters and electrical impedance changes
Quality systems in automated plateletpheresis in hospital based blood transfusion services in north India
The first advanced Quality Management Training course for blood transfusion services in the Western Pacific Region
Validation of HemoCue Plasma/Low Hb photometer in transfusion medicine
Determination of haemolysis in RCC's - should all supernatants be filtered before analysis?
Validation of BacT - Alert plastic BPA and BPN culture bottles for use in testing of blood components
Management of returned blood products in CITM - analysis 2000-2004
A methodic approach of information management, a solution for process management of hemovigilance
Training in transfusion medicine in Bulgaria
Education in transfusion medicine – Macedonian experience
Experience of postgraduate education on transfusiology for doctors
Experience of organization of special postgraduate education on extracorporal hemocorrection and photohemotherapy
Training of general practitioners in blood banking and transfusion medicine
Change of blood consumption in Turkey
Training of general practitioners in blood banking and transfusion medicine
Mannose-binding-lectin (MBL) levels and blood transfusions related to postoperative complications after cardiac surgery
Relationship between leukocyte-depleted erythrocyte concentrates and cytokines in cardiac surgery
Anemia and blood transfusion practice in critically ill patients
Consumption of blood products in a large, general hospital
Prophylaxis of RHD immunization in Croatia on the threshold of its accession to the European Union
Consumption of plasma derivates in Croatia
RhD alloimmunization in a university hospital
The use of blood and blood products in patients who are hospitalized and treat in the internal department in Gevgelija (2000-2004)
Blood transfusion requirement in femoral neck fracture repair
Fresh frozen plasma guidelines and practices
Use of blood at the clinical wards medical centre - Kumanovo
Improvement in blood component therapy
A new point of care instrument to determine the haemostatic status in thrombocytopenic patients
Quality control of pre-storage leukodepleted red cell concentrates
The use of blood and blood components in teaching hospital Maribor
The use of blood components in cardiosurgery in teaching hospital Maribor in the period 1998-2004
Prevention of posttransfusion reactions with use of leucoreduced erytrocyte concentrates in therapy of secondary anaemia in patients with malignant disease
Combined patient based analyses of RCT's comparing buffy-coat depleted RBC transfusions with filtered RBC transfusions
Selection of phenotyped blood for pre-menopausal females in the UK and mainland Europe
GPIB expression as ultimate in vitro test as a measure to predict platelet survival post transfusion
Transfusion and lung injury
Anti-neutrophil antibodies induced-neutrophil activation and -transfusion reactions
Implementation of a hemovigilance system in Norway
Hemovigilance. Immediate transfusion reactions
Measurements of IGE immunoglobulin in thalassemic patients, before and after blood transfusion
Serum levels of natriuretic peptide (BNP) in multitransfused thalassemic patients
Proinflammatory cytokines in peripheral circulation of blood donors
TRALI complication postsurgically in elderly female
Cumulative data on total and serious adverse reactions and events associated with the transfusion of blood components in 1997-2003 in Hellas
Washed RBC for thalassemic patients (TP)
Building the Slovenian haemovigilance system
Clinical and hematological observations on experimental repeated blood transfusions in Iran's native cattle
Three years survey of acute post-transfusion reactions in the Hradec Kralove University Hospital
Flowcytometric evaluation of anti-HLA I antigens and platelet-specific antigens in patients with hematological disorders who received platelets concentrates
Post transfusion purpura
3 years of transfusion reaction reports - a summary of the Haemovigilance Programme in Singapore
Adverse reactions of blood transfusion
Trend analysis of transfusion reactions
Results of the first year of national hemovigilance reporting in the Netherlands
Post transfusion hepatitis in Israel - what's the evidence?
Anti-HIV positive and negative standard panels are the main newly created instruments for HIV quality control and prevention system in Uzbekistan
Anti-HBcore testing in blood donors as surrogate of other transmissible diseases by blood transfusion
Hepatitis B residual risk in transfusion
Confirmation by supplemental assays of anti-HCV (Elisa) seropositive blood donors and post-notification counselling (1992-2003)
Epidemiological and demographic factors of anti-HCV infected blood donors (1992-2002)
Abstract withdrawn
Risk reduction by trombocytapheresis
Distribution of blood donors according to marital status and HBV infection
Presence of HBV infection in blood donors according the profession
Presence of HBV infection in blood donors related to living space and facilities
Distribution of blood donors concerning the use of condoms as protection from HBV infection
Prevention of transfusion transmissive bacterial infection in working unit transfusiology in the medical center in STIP
Seroprevalence of cytomegalovirus, hepatitis B, hepatitis C and human immunodeficiency virus antibodies among volunteer blood donors
Virus testing of blood donors in Albania
Anti-HIV antibodies in blood donors in the regions of Tetovo, Ohrid and Veles from 2000-2004th year
Anti-HCV antibodies in the blood donors from the regions of Veles, Tetovo and Ohrid from 2000-2004th year
HBV-AG positive blood donators in the regions of Ohrid, Tetovo and Veles from 2000-2004th year
First months of using Procleix Ultrio nucleic acid testing (NAT) assay
Bacterial monitoring of platelets - is the extension of selflife feasible
Bacterial screening of platelet concentrates using BacT/Alert system - six year's experience in Croatian Institute of Transfusion Medicine
Transfusion transmitted diseases in multitransfused patients with hematological malignancies
Validation of the Nuclisens - COBAS Amplicor system for blood screening
Implementation of an enhanced bacterial detection system in leucodepleted apheresis platelets stored in additive solution
Detection of hepatitis B virus DNA (PCR) in HBsAg negative, anti-HBC positive in Iranian blood donors - preliminary study
Early detection of hepatitis B surface antigen
Delta infection and hepatitis B virus replication in Iranian patients with chronic hepatitis B
Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection
Prevalence of parvovirus B19 and hepatitis a virus in Portuguese blood donors
Comparison of HBV-DNA quantitative testing results on Cobas Amplicor and Cobas TaqMan instruments
Detection limit of bacteria detection with Scansystem™ in platelets stored in additive solution
The presence of obligatory markers for blood transmitted diseases among first time voluntary blood donors in the South Backa Region in the period 2000-2004
HCV core antigen detection and quantification of viremia in the ‘window period’ of donors identified by routine HCV RNA screening in Poland
Seropidemiological study of hepatitis C in Albania blood donors
HBV prevalence among autologous blood donors in Albania
HCV pre-seroconversion blood donation case at Nikaia General Hospital of Greece
Evaluation of an enhanced bacterial detection system for screening of contaminated platelets
Hepatitis B in blood donors
NAT screening for HCV HIV HBV in blood donors. Analytical evaluation and management one year after implementation with Chiron ULTRIO Procleix
Preliminary results of mini-pool and single donation HBV DNA screening in Poland
Bacterial contamination in stored platelets
Cost-effectiveness of expanded HIV screening of blood donations in Ghana
Screening HbsAg anti HIV1/2 and anti HCV antibodies in blood donors and patients in Clinical Hospital Center Zvezdara Belgrade and view to intermediate and false positive results
Quality control programme for nucleic acid screening in blood service laboratories
Prevalence of hepatitis B and C among blood donors and in a minority group of pregnant women
Implementation of nucleic acid test screening in Thai blood donors
The prevalence of major transfusion-transmissible infections among blood donors in Istanbul, Turkey
Compared overview for presence of transfusion transmitted infections to the voluntary and family donators within the last five years in the region of Tetovo
An automated chemiluminescent assay for the detection of antibodies to treponema pallidum using the Architect® system
Monolisa HCV Ag–Ab Ultra test evaluation on Bio–Rad Evolis automated microplate processor
Operational evaluation of pall eBDS bacterial detection system
Prevalence of viral markers among blood donors 1997–2004
Development and characteristics of working HBsAg standard
The prevalence of HBV serologic markers in the population of blood donors in Northeastern department of Greece
Earlier detection of human immunodeficiency type 1, hepatitis C and hepatitis B viruses using the Procleix® Ultrio™ assay on the Procleix® system and Procleix® TIGRIS® system compared to serology
Early sampling for sterility testing of platelet concentrates implies the risk of false–negative test results
Effectiveness and limitations of methods for platelet bacteria screening – how to apply which screening method?
Results from the Procleix HIV-1/HCV and HIV-1/HCV/HBV (Procleix Ultrio) assays for the detection of HIV-1 RNA, HCV RNA and HBV DNA in blood donors of two blood transfusion centers of SW Greece
The majority of false positive results of the reconfigured BacT/ALERT system for sterility testing are caused by malfunctioning cells in the incubation units
Markers of hepatitis B, C, and d in patients with hemophilia
HIV P24 AG screening in Argentinean blood donors
Transfusion transmitted viruses in Romania – 2000–2004
Prevalence of west Nile virus in central Europe
Two years' experience of nucleid acid technology (NAT) screening of single donations for HIV 1 RNA/RNA and HIV 1 RNA/HCV-RNA/HBV DNA
NAT screening for HCV-RNA and HIV-RNA. Experience of the Porto Regional Blood Center
HCV NAT testing in blood donors – pilot study in Czech Republic
NAT for parvo B19 – five years experience
Evaluation of an immunoenzymatic assay anti Treponema pallidum for screening blood donations
HCV genotypes in central Portugal
Routine use of positive controls improves bacteria detection with Scansystem
A new FACS-based method to screen platelet concentrates for bacterial contamination
Optimised Scansystem™ platelet kit enables detection of bacteria in apheresis platelet concentrates 24h after spiking
Automated versus manual extraction for HCV-RNA detection with the Roche Cobas Ampliscreen HCV-V 2.0
Performance evaluation of the new blood screening PRISM® HIV antigen-antibody combination assay
Surveillance of the infectious test results of blood donors through five years and affecting factors
Low prevalence of HTLV-I/II infection markers
Toxoplasma antibodies in Iranian blood donors
Serological blood detection in multitransfused thalassemic patients
Further investigation of human T-cell lymphotropic virus I/II indeterminate blood donors
Epidemiology of HTLV I/II in blood donors and pregnant women
Seroepidimiology of transfusion transmitted diseases in the state of Achaia
Molecular mimicry between NS5A protein of hepatitis G virus and human P56-LCK tyrosine kinase
HBV infection among first-time blood donors in Italy
Prevalence of infectious disease markers in blood donors of South-Eastern Serbia
Detection of hepatitis C core antigen and comparison of six anti-HCV assays in testing hemodialysed patients
International comparison of performance of Abbott PRISM assays used for blood donor screening
Simultaneous HIV-1 and HCV NAT screening using a single nucleic acid extraction
The blood screening system 200 automated NAT system for multiplex screening of HCV, HIV-1 (Groups M&O), HIV-2, and HBV
Three-year review of HCV-RNA testing. Acute HCV seroconversion in a Greek blood donor
Ethical aspects of medical publishing
The changing face of the donor
Donor selection throughout Europe
Blood donation
Establishing a national adverse event reporting system for blood donors - a prospective study of 1.8 million donor attendances in England and north Wales
The community role in enhancement of voluntary, Non-remunerated blood donation in the new millennium
Problems and possibilities
Blood donor magnetic card
Emerging technologies in transfusion. DNA based assays
High-throughput genotyping of red cell and platelet antigens by DNA microarray, a pilot study
Evaluation of molecular weak D typing in daily practice 2002-2004; prevention of mistyping partial d and identification of a new weak D type
Non-deletional ABO*O alleles frequently cause blood donor typing problems
The prediction of the fetus Kell blood group reduces aggressive interventions
Evidence-based transfusion medicine
Academic training programmes in transfusion medicine in Europe
Temple study
A program to reduce allogeneic blood exposure in patients undergoing HIP arthroplasty
Use of pre-storage leukoreduced red cells (LR-RBCS) vs standard RBCS (S-RBCS) in cardiac surgery patients is associated with significant intermediate-term (2-12 month) survival benefit
Thalassaemia
Should patients with thalassemia intermedia be regularly transfused?
S-303 pathogen inactivated red blood cells in patients with hemoglobinopathies participating in chronic transfusion programs
The impact of prestorage leucodepletion on the immediate transfusion adverse events of patients with thalassaemia major
Viral inactivation/elimination of plasma derived medicinal products
Viral safety of plasma products
Intercept plasma retains a broad spectrum of proteins necessary for hemostasis without thrombin generation or complement activation
Application of the European directive 2004/33/EC
Development and training courses for cell salvage operators
Modern concepts of autologous hemotherapy
Hyperoxic hemodilution
Efficacy and safety of postoperative reinfusion of autologous shed blood in elective orthopaedic surgery patients. A randomized, controlled pilot-study
Experience with autologous predonation in elective orthopedic surgery
Colloid solutions and their establishment in clinical practice
Recombinant human erythropoietin therapy in critically ill patients - a dose response study*
Thrombocyte immunology - the role of antibodies related to transfusion and pregnancy
A new container for 9-day storage for platelets
The effect of irradiation on white cell reduced platelet concentrates, stored for 7 days
A novel system for storage of pooled buffy coat platelet concentrates (BC PC) in a glucose containing additive solution (PAS-G)
Platelet transfusions in patients alloimmunised with HPA antigens alone or together with HPA antigens
Inactivation of bacteria
Prevention of bacterial contamination of blood components
Look back studies of anti-HCV negative/HCV RNA positive blood donors identified low viremic donation not detected by mini-pool NAT
Costs and effects of bacterial culturing and pathogen reduction in the Netherlands
Bacterial screening of platelet concentrates to increase shelf life to 7 days using an automated microbial detection system
Evaluation of a new system for automated multiplex NAT blood screening
Human tissue banking
Directed cord blood banking for transplantation
Increased yield of mature platelets in cultures of CD34-enriched cord blood cells maintained at 39°C
Weak RHCE expression in a patient with new polymorphisms in RHCE-exon 5
Mirasol® PRT treatment inactivates human peripheral blood mononuclear cells (PBMNCs)
Impact of transfection with total RNA of K562 cells upon antigen-presenting, maturation and function of human dendritic cells from PBMNCs
Immunomodulatory effects of intravenous immunoglobulin (IVIg)
IVIg in autoimmune neuromuscular disorders
Donor-lymphocyte infusion
Platelet glycolytic flux increase stimulated by UV stress is not the direct cause of platelet morphology and activation changes
Results of a subchronic toxicology study using the Mirasol® PRT system for pathogen reduction of blood products
Sterilization of plasma-reduced platelet concentrates with thionine/light and UVB
The blood screening system 200 automated NAT system for multiplex screening of HCV, HIV-1 (groups M & O), HIV-2, and HBV
Prospective active hemovigilance plan for intercept platelets in Europe
Quality of Theraflex MB-plasma during storage and treatment
Validation of intercept treatment of pooled platelets
Transfusion of thrombocytopenic patients using INTERCEPT Platelets prepared with photochemical treatment with amotosalen and UVA light and stored for 7 days
Modification of the S-303 RBC pathogen inactivation process results in normal S-303 RBC vipility in rpbits hyper-immunized to S-303
Case report
Reference lporatory in Kuwait
Frequency of O, A, B, P and Rh (D) antibody in the region Gevgelija-Valandovo (1989-2004)
Retrospective review of alloimmunization frequency in the patients of the Northeastern Greece
Severe hemolytic reaction due to anti-J K3
Differential warm adsorption of alloantibodies to a high frequency antigen
Evaluation of validity of the expired enzymetreated 0.8% red cells in antibody identification gel tests using Nacl cards
Evaluation of validity of the expired 0.8% red cells in antibody identification gel tests using Liss/Coombs cards
Unexpected anti-Wr(a) antibody in a nontransfused male patient
Validation of antibody screening by filtration technique
Weak D and Rh(D) phenotype prevalence in the Rh (D) negative blood donors of the university hospital, Coimbra (Portugal)
The value of quantitative ELAT in the patients with warm-type autoimmune haemolytic anaemia
Auto-anti-H compatible only with Bombay phenotype (OH) units
The needing of minimising errors in determination of allo- and auto-immunization in pregnant women
Applicpility of identification of Kidd system in voluntary donated RBC units
Affinity of monoclonal RHD reagents for weak D
Reduction or lack of reactivity of anti-Vel with dithiothreitol (DTT)-treated red cells
Positive antibody tests without detecTable specific antibodies; part I
Positive antibody tests without detecTable specific antibodies; part II
Detection and identification of red cell alloantibodies in cardiac and cardiac surgery patients
Anti-C(RH4) in RHD negative pregnant women
Study on the frequency of red cell phenotypes (e.g. Duffy, Kidd and MNS blood group system) in our local population
Miltenberger phenotypes among Taiwanese
Comparison between two column agglutination tests for red cell antibody detection
Immunogenic potential of RHD variant RoHar
Unusual PO grouping discrepancy - inhibition of anti-B reagent by isolated increase of plasmatic b substance in a patient with group P and pancreatic cancer
Implementation of the AutoVue Innova, an upgraded column agglutination technology (CAT) for pre-transfusion testing in a large blood estplishment
Clearance of senescent erythrocytes in young and old individuals
Digital image processing for evaluation of the intercellular binding energy in the erythrocyte adhesion mediated by monoclonal anti-A antibody
Characterization of monoclonal antibody on red blood cell by flim-fret and optical scanning microscopy
Erythrocyte autoantiboby formation in sickle cell patients
Forward and reverse blood grouping with lateral flow based assays
The performance of the AutoVueTM system for red cell antibody screening of blood donors during 2000-2004
Study of weak D in populations
Distribution of RH and Kell antigens and phenotypes of RBC among patients with homozygous betta-thalassemia in Azerbaijan
Hyperhaemolysis in sickle cell disease due to complement activation. Tessa thorp RCI national blood service Manchester UK
Appearance of Chido and Rogers antibodies during the last two months of pregnancy
RBC alloantibody frequency and their prevalence within Chinese, Malay and Indian community in Singapore
Positive direct antiglobulin test (DAT) in newborns
Red cell incompatibility in pretransfusion testing
Multiple isoforms excluding normal RHD mRNA detected in RH blood group del phenotype with RHD 1227a allele
The effect of pre-and post-storage filtration on platelet rich plasma
Metpolic suppression suppresses plateletphagocytes interaction
Platelet compatibility testing and alloimunization in multiply transfused hematologic patients
Neonatal alloimmune thrombocytopenia
HPA-HLA neonatal alloimmune thrombocytopenia (NAITP)
Anti hpa-9bw (Maxa+) feto-maternal alloimmunization, a clinically severe neonatal thrombocytopenia
Severe immune thrombocytopenia due to HPA-1a host-derived antibodies after non-myeloplative allogeneic hematopoetic stem cell transplantation for multiple myeloma
Severe neonatal alloimmune thrombocytopenia with anti-HPA-5B antibodies
Partial results of the incidence of heparin induced thrombocytopenia type II
Neonatal alloimmune thrombocytopenia (NATP) due to anti-HPA-1a and beneficial effect of random donor platelet transfusion, IVIG and corticosteroides
High prevalence of weak d type 2 allele in Portugal
Analysis of RHD zygosity in different RH phenotypes
Anti-D antibody induction in a patient of African origin with 3 single mutations in the RHD gene
Three new polymorphisms in patients with serologic suspect of weakened expression of RHC-antigen
Inheritance of a RHD cat VI type II in a twin pregnancy
Prevalence of weak D in different ethnic populations
Polymorphism of PO subgroup gene in Koreans
Evaluation of a multiplex SNaPshot-PCR method for red blood cell marker genotyping
Quantification and quality control of monoclonal antibody using an optical sensor based on the laser reflectometry technique
Human neutrophil antigen (HNA-1A, -1B AND -1C) genotyping in Croatian population
HLA-B*1586, a new chimeric HLA B15/B22 allele characterized by haploprep separation and sequence-based typing
Protection with human anti-D immunoglobulin to a D- patient who was transfuse with D+ blood
National human immunoglobulin G for intravenous use in the therapy of surgical patients
Study of donor lymphocyte storage, a comparison between room temperature and refrigerator storage during three days
Cryopreservation of lymphocytes in 5% or 10% di-methyl-sulfoxid (DMSO) gives simular in vitro result after storage and thawing
Detection of transfusion-associated microchimerism (TA-MC) using real-time quantitative PCR targeting insertion/deletion polymorphism
Chimeric donor cells transfer MCMV specific immunity in a murine transfusion microchimerism model
Validation of a simple algorithm to determine patients who do not benefit from autologous blood donation before undergoing radical prostatectomy
Use of Darbepoetin-alpha in preoperative autologous blood donation
Preoperative autologous blood donation in a few cases with allo- and auto-antibodies
Hemoglobin levels before autologous blood donation and the need for transfusion in primary total hip and knee arthroplasty
Preoperative autologous blood donation in elective orthopedic surgeries
Fibrin sealent influence on colagen production in colons
The study of the use of the safest blood (autologous blood transfusion) through preoperative blood donation (PBD) in 100 surgery patients
The usefulness of the 111indium-oxine autologous platelet Gel [111indium-oxine-agp] graft scintigraphy to evaluate osteoinduction in patients with jaws bone defects
Serial blood donations in a Ko pregnant woman with the use of recombinant erythropoietin for intrauterine transfusions of severe hemolytic disease of the newborn due to anti-Ku
Transport validation in extreme temperature conditions
Collection and preparation of double homologous leuko-reduced red blood cell concentrates (RBCC) using haemonetics MCS®+
Evaluation of a new platelet storage bag for pooled platelet concentrates
Pada a new platelet function assay
Collection and preparation of homologous leuko- reduced platelet and red blood cell (RBC) concentrates using haemonetics MCS® +
Use of OrbiSac system for the preparation of platelet concentrates (PC)
Increased production of plasma components from male donors
Quality assessment of buffy coat-derived platelets prepared from leucoreduced whole blood
Performance qualification of the Fresenius HemoCare bloodpack
The cryopreservation and thawing of red blood cells using haemonetics ACP 215
Full process validation of the Pall Leukotrap WB for the in-line preparation of leukoreduced blood components
Fully automated separation of whole blood into components with the Atreus 3C system
Investigation of type of sterile connections on in vitro quality of blood products
Utilization of collected blood units – ratio between collected and actually used blood units
Blood processing
In vitro effects of platelet storage at 4°C
Evaluation of leucodepleted autologous whole blood stored for 42 days in CPDA-1
Exclusion of female donors from fresh frozen plasma production for TRALI prevention
Prestorage pooled whole blood derived platelet concentrates maintain acceptable in vitro function to day 7
Quality of platelet concentrates stored for 7 days and the effect of gamma irradiation
Cytokine release during storage of buffy coat platelet concentrates produced manually and automatically
The quality of cryopreserved vs liquid stored platelets
Bacteremia is the main risk for contamination of stem cells
Search for HLA compatible hematopoietic stem cells donors within the family
10-year experience with the search for HLA compatible unrelated stem cell donors
Pre-freezing and post-thawing quality controls in umbilical cord blood assigned for transplantation
Bone marrow and abnormalities of hematopoietic microenvironment
HLA genotyping of cord blood bank
Infection in bone marrow transplant patients
Exchange transfusion in neonatal intensive care unit
Detection ABO blood group system antibodies of neonatal using fully automated column agglutination technology (Auto-Vue)
Management of pregnancies with alloimmunization
Erithrocite transfusion in pediatrics
The use of red blood cells at the clinic for obstetric and gynecology in the clinical center in Skopje from January till May 2004
Always actual monitoring of fetomaternal haemorrhage and d or g immunisation during pregnancy – an illustrative case report
Neonatal transfusion
Blood component therapy in neonates admitted in Shahid Beheshti hospital in Kashan, Iran, during one year
Relevance of enzymatic techniques for detecting antibodies in antigen d sensitized pregnant women
Guidelines and neonatal transfusion audit
Death causes in patients suffering from beta thalassaemia major in Romania
Genetic polymorphism of the HLA-DP region in Croatian
The relationship between T-cell levels and CMV infection in drug addicted HIV+ persons
Effects of phytoestrogenes on platelet activity
Effects of miscellaneous antioxidants on platelet activity
Influence of storage on RBC morphology analysed by flow cytometry and light microscopy
An audit of discarded blood and components
Error risk
Fibrinogen concentrate prepared with single and double cryoprecipitation method(s) from fresh frozen plasma stored at various temperatures
Different methods of preparation of fibrinogen concentrate for fibrin glue
Plasma fractionation program in Greece
Prevalence of hereditary hemochromatosis in patients with hepatitis B or C
Donor blood group declaration before donation can be used as a tool for electronic crossmatching(E-XM)
Routine antenatal anti-D immunoglobulin prophylaxis, is it appropriate?
Frequency of HLA a201 haplotype expression and lymphocyte phenotypic analysis of metastatic cancer patients in comparison to healthy donors, during screening for HLA-compined peptides immunization
The first transport of preserved blood in south-east Europe
Automated transfusion service using column agglutination technology fully automated system (Auto-Vue)
Exosomes secreted by dendritic cells (DCS)
Simple technique to study erythrocyte CD44 expression
A new technology for crossmatching tests adapted to a fully automated system
ABO blood group distribution in patients with myocardial infarction in the middle Moravia region
The presence of a p53 responsive PIG3 gene polymorphism in healthy blood donors and in lung cancer patients
Rhesus D category VII variant appearing as normal D by a standard screening gel test for the RH D antigen
Who cares about the quality of life of the chronic patients treated with blood products?
Transfusion medicine practice in surgically treated urology patients
Improvement of the logistics in transfusion medicine and of the safety of blood transfusion by radio frequency identification
Our experiences with the immunohaematological analyser OLYMPUS PK 80
Hepatitis B virus DNA testing by nested-PCR, PCR-ELISA and hybrid capture II from a blood and blood products
Blood component therapy
Blood groups and ascariasis
The use of filters for leucocyte depletion in anemic patients on maintenance hemodialysis
Evaluating the safety of potassium level in stored blood units after being irradiated with gamma irradiation UAE experience
Analysis of the use of blood components in treatment of surgical patients in ten years period in Iran (1994-2003)
National test red blood cell panel - 12 years experience
Blood units transfused to patients with upper gastrointestinal track bleeding and haemostasis
F.F.P. units disposal
Acquired factor V inhibitor
Recombinant factor VIIa in treatment of severe thrombocytopenic patients
Prevalence of three genetic risk factors among thrombotic patients
Hypofibronogenaemia
Bernard Soulier Syndrome in Iran
Recombinant factor VIIa (rFVIIa) treatment decreases FVIII inhibitor titre
Specificity and clinic importance of anti-erythrocyte antibodies
Improved predictive factors of response for myelodysplastic syndrome patients treated by the combination of erythropoietin and G-CSF
Comparison of leucoflex LCR5 for leucodepletion of red cells concentrates, to a new automated collection device
Evaluation of an automated blood collection system with standard ratio of anti-coagulation and integrated filter for whole blood leucodepletion
Evaluation of a post-storage filter for WBCs with an incorporated waste bag for washing RCCs
Pan-European blood safety alliance
Gene therapy for haemophilia
Gene therapy for thalassemia
Practical approach to transfusion in autoimmune hemolytic anemia (AIHA)
Autoimmune neutropenia
A rare case of ‘Coombs negative’ autoimmune haemolytic anaemia due to red cell autoantibodies of IgA class
Therapeutic approach to alloimmune neonatal neutropenia due to anti HNA-2a alloimmunization with severe and prolonged neutropenia but mild clinical course
Male donors for the production of fresh frozen plasma
Maximising the blood supply chain in times of shortage
Transfusion during disaster
Rehabilitation of blood transfusion service in Azerbaijan
Updating of the Russian law ‘concerning the donation of blood and blood components’
Types of blood banks in Turkey and steps toward centralization
Controversial clinical questions considered in a medical opinion forum by physicians for the advancement of transfusion medicine (PATM)
Impact of EPO treatment on transfusion requirements in myelodysplasia
Can iron administration reduce peripartum blood transfusion
Iron therapy in orthopaedic surgery
Multiple erythrocytapheresis in therapy of hereditary hemochromatosis
Donors anaemisation and iron depletion after the donation of 2 units of RBC by apheresis
HFE mutations frequency and the role of H63D mutation on iron overload in a blood donors population in Italy
Alterations of CD43 expression in transfusiondependent myelodysplastic syndromes
Is predeposit autologous donation worthwile? - Yes